日本儿童常规水痘疫苗接种计划与COVID-19疫情对水痘及带状疱疹发病率及医疗资源使用的影响
COVID-19感染预防措施带来水痘发病率额外下降57.2%(95%CI 44.5-67.1)。带状疱疹的变化相对较小。
要点
- 2014年常规水痘疫苗接种计划后水痘发病率下降45.6%(95%CI 32.9-56.0)。
- COVID-19感染预防措施后水痘发病率额外下降57.2%(95%CI 44.5-67.1)。
- 带状疱疹发病及医疗费用变化相对较小。
核心结论
- 水痘发病率及医疗资源使用受常规免疫规划与COVID-19感染预防措施较大影响,而对带状疱疹的影响相对较小。
- 本研究表明免疫与感染预防措施大幅改变了儿童感染病实践。
研究设计与样本
- 采用中断时间序列分析评估2014年常规水痘疫苗接种计划及COVID-19感染预防措施对水痘和带状疱疹发病率及医疗资源使用的影响。
主要发现
- 2014年常规免疫规划引入后,水痘发病率水平变化为下降45.6%(95%CI 32.9-56.0),抗病毒药物使用下降40.9%(95%CI 25.1-53.3),相关医疗费用下降48.7%(95%CI 38.2-57.3)。
- COVID-19感染预防措施与水痘发病率额外水平变化相关,下降57.2%(95%CI 44.5-67.1),抗病毒药物使用下降65.7%(95%CI 59.7-70.8),医疗费用下降49.1%(95%CI 32.7-61.6)。
- 带状疱疹发病率和医疗费用变化相对较小,疫苗计划后呈下降趋势中水平变化升高9.4%,COVID-19疫情后呈下降趋势中水平变化降低8.7%。
- 2014年后出生儿童的带状疱疹累计发病率低于2014年前出生儿童。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the epidemiological trends in pediatric varicella and herpes zoster incidence and changes in healthcare resource use from 2005 to 2022 using a nationally representative database in Japan. MATERIALS AND METHODS: We conducted a retrospective observational study consisting of 3.5 million children with 177 million person-months during 2005-2022 using Japan Medical Data Center (JMDC) claims database in Japan. We investigated trends in incidence rates of varicella and herpes zoster and changes in healthcare resource use (e.g., antiviral use, office visits, and healthcare costs) over 18 years. Interrupted time-series analyses were used to investigate the impact of the routine varicella vaccination program in 2014 and infection prevention measures against COVID-19 on incidence rates of varicella and herpes zoster and related healthcare utilization. RESULTS: After the introduction of the routine immunization program in 2014, we observed level changes in incidence rates (45.6 % reduction [95 %CI, 32.9-56.0] of varicella cases, antiviral use (40.9 % reduction [95 %CI, 25.1-53.3]), and relevant healthcare costs (48.7 % reduction [95 %CI, 38.2-57.3]). Furthermore, infection prevention measures against COVID-19 were associated with additional level changes in varicella rates (57.2 % reduction [95 %CI, 44.5-67.1]), antiviral use (65.7 % reduction [59.7-70.8]), and healthcare costs (49.1 % [95 %CI, 32.7-61.6]). In contrast, the changes in incidence and healthcare costs for herpes zoster were relatively small, which showed 9.4 % elevated level change with a decreasing trend and 8.7 % reduced level change with a decreasing trend after the vaccine program and the COVID-19 pandemic. The cumulative incidence of herpes zoster in children born after 2014 was lower than that before 2014. CONCLUSIONS: Varicella incidence and healthcare resource use were largely affected by the routine immunization program and infection prevention measures against COVID-19, while these impacts on herpes zoster were relatively small. Our study indicates that immunization and infection prevention measures largely changed pediatric infectious disease practices.
引用
- Uda K, Okubo Y, Tsuge M, et al. Impacts of routine varicella vaccination program and COVID-19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan. Vaccine. 2023. PMID: 37400282. doi:10.1016/j.vaccine.2023.06.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。